跳至主要内容
临床试验/CTRI/2022/07/044075
CTRI/2022/07/044075尚未招募未知

A randomized, double blinded, placebo controlled comparative study to evaluate the effect of ASFP001/21 and SMXP001/22 on improvement in quality of life in healthy volunteers with mild to moderate functional dyspepsia symptoms.

Akay Natural Ingredients Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Fulfilling Rome IV diagnostic criteria for functional dyspepsia
  • 2.Female subjects who are non-pregnant, non-lactating, postmenopausal, surgically sterilized, or using a medically acceptable form of birth control, as determined by the investigator
  • 3. Must be willing and able to give informed consent and comply with the study procedures.

排除标准

  • 1.History of peptic ulcer, gastro oesophageal reflux disease, gastro intestinal surgery or any other clinically significant gastro intestinal disease, gastrointestinal bleeding, mechanical obstruction, perforation, gastrointestinal cancer.
  • 2.Subjects who have taken antibiotics or any other drugs in last 2 weeks with primary site of action in the gastro intestinal tract
  • 3.History of psychiatric illness
  • 4.History of congestive heart failure or uncontrolled hypertension
  • 5.Subjects with abnormal haematological or biochemical parameters

研究者

发起方
Akay Natural Ingredients Pvt Ltd

相似试验